Organon Canada Inc.
Organon Canada Inc. has met with MPs 7 times since January 2024, reaching 5 MPs across 3 parties. Most recent contact: November 25, 2025.
What they're asking for
In the registry's own words. Descriptions are only filed for meetings since mid-2024.
Organon Canada’s objective is to preserve a regulatory framework which creates a favourable business environment for the development of the life science sector, including biosimilar drugs and women’s health products, which are the company’s main sectors of activities.
November 25, 2025 · Marilyn Gladu · Liberal · Health; Economic Development
Representations relating to the conditions under which biosimilar drugs are marketed and reimbursed in Canada. More specifically, representations are made to support a favorable and knowledgeable environment to implement new or improve current women’s health programs, the integration of biosimilar drugs into the drug plans administered by the Federal Government and to emphasize the importance that the federal government respect their respective jurisdiction with respect to the approval, marketing and reimbursement of drugs.
November 25, 2025 · Tom Kmiec · Conservative · Health; Industry; Science and Technology
Full meeting log
7 MP-directed communications since January 2024, from the Registry of Lobbyists.
| Date | MP |
|---|---|
| 2025-11-25 | Marilyn Gladu · Liberal |
| 2025-11-25 | Tom Kmiec · Conservative |
| 2025-11-25 | Tom Kmiec · Conservative |
| 2025-11-25 | Louis Plamondon · Bloc Québécois |
| 2025-11-25 | Louis Plamondon · Bloc Québécois |
| 2025-09-25 | Mélanie Joly · Liberal |
| 2024-11-18 | Andréanne Larouche · Bloc Québécois |